Kaufman, J., Owen, D. H., Memmott, R. M., Otterson, G. A., He, K., Presley, C. J., … Carbone, D. P. (2023). Novel STK11 differentiation phenotype classifier STK11-DPC: Immunosuppressive tumor microenvironment (TME) and response to immune checkpoint blockade (ICB) in STK11-deficient NSCLC. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 41).

Kaufman, Jacob, Dwight Hall Owen, Regan Michelle Memmott, Gregory Alan Otterson, Kai He, Carolyn J. Presley, Daniel Spakowicz, et al. “Novel STK11 differentiation phenotype classifier STK11-DPC: Immunosuppressive tumor microenvironment (TME) and response to immune checkpoint blockade (ICB) in STK11-deficient NSCLC.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 41, 2023.

Kaufman J, Owen DH, Memmott RM, Otterson GA, He K, Presley CJ, et al. Novel STK11 differentiation phenotype classifier STK11-DPC: Immunosuppressive tumor microenvironment (TME) and response to immune checkpoint blockade (ICB) in STK11-deficient NSCLC. In: JOURNAL OF CLINICAL ONCOLOGY. 2023.

Kaufman, Jacob, et al. “Novel STK11 differentiation phenotype classifier STK11-DPC: Immunosuppressive tumor microenvironment (TME) and response to immune checkpoint blockade (ICB) in STK11-deficient NSCLC.” JOURNAL OF CLINICAL ONCOLOGY, vol. 41, no. 16, 2023.

Kaufman J, Owen DH, Memmott RM, Otterson GA, He K, Presley CJ, Spakowicz D, Shields PG, Zhang X, Boyle TA, Cress WD, Wood K, Ready NE, Li L, Li Z, Carbone DP. Novel STK11 differentiation phenotype classifier STK11-DPC: Immunosuppressive tumor microenvironment (TME) and response to immune checkpoint blockade (ICB) in STK11-deficient NSCLC. JOURNAL OF CLINICAL ONCOLOGY. 2023.